An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Avivagen to Attend CEM Sponsored Alpha North Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) will present at the Annual Alpha North Capital Event in the Bahamas from March 25-27, 2022. This invite-only conference connects growth-stage companies with capital finance professionals through one-on-one meetings and networking. Avivagen focuses on products that enhance feed intake and immune function in livestock, companion animals, and humans. The company is known for its OxC-beta™ technology, a non-antibiotic solution promoting health in livestock, which is currently available in several countries.
Positive
None.
Negative
None.
OTTAWA, Ontario--(BUSINESS WIRE)--
Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, is pleased to announce that it will be a presenter at the Annual Alpha North Capital Event organized by CEM Events (CEM.ca) which takes place in The Bahamas between March 25 - 27, 2022. The invite only conference introduces growth-stage companies to active top-level capital finance individuals through a day of scheduled one-on-one meetings and networking activities. Avivagen will be represented by Mr. Kym Anthony, CEO and Dr. Jamie Nickerson, President.
About Avivagen Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada. For more information, visit www.avivagen.com. The contents of the website are expressly not incorporated by reference in this press release.
About OxC-beta™ Technology and OxC-beta™ Livestock
Avivagen’s OxC-beta™ technology is derived from Avivagen discoveries about β-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colours. Through support of immune function the technology provides a non-antibiotic means of promoting health and growth. OxC-beta™ Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds. The product is currently available for sale in the United States, Philippines, Mexico, Taiwan, New Zealand, Thailand, Brazil, Australia, and Malaysia.
Avivagen’s OxC-beta™ Livestock product is safe, effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters. Numerous international livestock trials with poultry and swine using OxC-beta™ Livestock have proven that the product performs as well as, and, sometimes, in some aspects, better than in-feed antibiotics.
Avivagen Inc. Drew Basek Director of Investor Relations
100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6
Phone: 416-540-0733
E-mail: d.basek@avivagen.com
Kym Anthony Chief Executive Officer
100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6
Head Office Phone: 613-949-8164
Website: www.avivagen.com
Source: Avivagen Inc.
FAQ
What is Avivagen Inc. known for?
Avivagen Inc. specializes in developing products that enhance feed intake and immune function in livestock, companion animals, and humans.
When is Avivagen presenting at the Alpha North Capital Event?
Avivagen will present at the Alpha North Capital Event from March 25-27, 2022.
What technology does Avivagen use for livestock health?
Avivagen uses OxC-beta™ technology, which supports immune function without antibiotics.
Where can Avivagen's products be purchased?
Avivagen's OxC-beta™ livestock product is available in the United States, Philippines, Mexico, Taiwan, New Zealand, Thailand, Brazil, Australia, and Malaysia.
Who will represent Avivagen at the conference?
Kym Anthony, CEO, and Dr. Jamie Nickerson, President, will represent Avivagen at the conference.
